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Summary
Background: The mammalian hair represents an un-
paralleled model system to understand both develop-
mental processes and stem cell biology. The hair follicle
consists of several concentric epithelial sheaths with
the outer root sheath (ORS) forming the outermost
layer. Functionally, the ORS has been implicated in the
migration of hair stem cells from the stem cell niche
toward the hair bulb. However, factors required for the
differentiation of this critical cell lineage remain to be
identified. Here, we describe an unexpected role of the
HMG-box-containing gene Sox9 in hair development.
Results: Sox9 expression can be first detected in the
epithelial component of the hair placode but then be-
comes restricted to the outer root sheath (ORS) and
the hair stem cell compartment (bulge). Using tissue-
specific inactivation of Sox9, we demonstrate that this
gene serves a crucial role in hair differentiation and that
skin deleted for Sox9 lacks external hair. Strikingly, the
ORS acquires epidermal characteristics with ectopic
expression of GATA3. Moreover, Sox9 knock hair show
severe proliferative defects and the stem cell niche
never forms. Finally, we show that Sox9 expression de-
pends on sonic hedgehog (Shh) signaling and demon-
strate overexpression in skin tumors in mouse and
man.
Conclusions: We conclude that although Sox9 is dis-*Correspondence: schedl@unice.fr
6 Present address: Max-Delbrück-Center for Molecular Medicine,
Robert-Rössle-Str. 10, 13092 Berlin, Germany.pensable for hair induction, it directs differentiation of
the ORS and is required for the formation of the hair
stem cell compartment. Our genetic analysis places
Sox9 in a molecular cascade downstream of sonic
hedgehog and suggests that this gene is involved in
basal cell carcinoma.
Introduction
The mammalian hair develops through intricate signal-
ing between the epithelial ectoderm and the underlying
mesenchyme (for review see [1]). The generation and
analysis of transgenic and knockout mice have iden-
tified numerous molecular players involved in this finely
tuned cross talk (for review see [2]). In the mouse, de-
velopment of hair pelage commences at E14.5 in re-
sponse to a mesenchymal signal, which induces a
thickening of the ectodermal epithelium (hair placode).
Epithelial cells continue to proliferate, invade, and then
engulf the underlying mesenchymal cells, the latter of
which will constitute the permanent dermal papilla. The
epithelial cells in close contact to the papilla make up
the highly proliferative matrix of the hair bulb. In re-
sponse to cues coming from the dermal papilla, matrix
cells rapidly divide and, while moving upwards, dif-
ferentiate into the three cell layers of the hair shaft (me-
dulla, cortex, and cuticle) as well as the different con-
centric cylinders of epithelial cells surrounding the hair
shaft. The inner root sheath (IRS) represents the most
inner epithelial lineage and is composed of three dis-
tinct cell layers: the IRS cuticle, the Huxley’s layer and
the Henle’s layer. The IRS is surrounded by the outer
root sheath (ORS), an epithelial compartment that is di-
rectly connected with the basal layer of the epidermis.
In contrast to all other mammalian organs, the hair
undergoes continuous cycling throughout adult life [3,
4]. In the mouse, a complete hair cycle lasts approxi-
mately 25 days and can be divided into three phases:
a phase of growth (anagen) characterized by significant
proliferation in the matrix of the hair, leading to an ex-
tension of the hair into the deeper layers of the dermis
and the growth of the hair shaft; regression (catagen),
which is mediated through apoptosis in the lower part
of the hair and which causes retraction of the hair folli-
cle; and, finally, a phase of inactivity (telogen). Re-
growth of a new hair involves the stimulation of stem
cells residing in a specific compartment of the hair con-
tiguous to the ORS and located near the arrector pili
muscle, the bulge [5–7]. This growth-induction process
seems to be mediated at least in part by signaling
through Shh and Wnt/β-catenin [8–12]. Stem cells leave
the bulge and migrate toward the matrix, where they
begin to proliferate and subsequently differentiate into
a new hair shaft [13]. How stem cells find their way to
the matrix is so far poorly understood, but it has been
shown that they migrate along the ORS, a finding that
may suggest that this cell layer provides important
cues to guide cells toward the hair bulb.
Sox9 is a member of the Sox gene family, which is
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more than 50% homology to the sex determining gene
Sry [14]. The HMG box can bind and bend DNA, and it
has been proposed that Sox genes encode architec-
tural DNA binding proteins. In addition to the HMG box,
Sox9 possesses a transactivation domain at its C termi-
nus [15], and it has been shown that it can activate
the genes Mis in testis [16, 17] and Col2aI [18] during
chondrogenesis in vitro and in vivo. Moreover, in vitro
studies suggest that Sox genes may also have a role in
RNA splicing [19], but in vivo evidence for such a func-
tion is still missing.
Human patients carrying mutations/rearrangements
in SOX9 locus suffer from campomelic dysplasia, a
skeletal malformation syndrome characterized by bow-
ing of the long bones, and high frequency of XY sex
reversal [20–22]. Studies in mice have confirmed the
pivotal role of Sox9 during chondrogenesis [23–25] but
also demonstrated an important function for this gene
in the formation of many organs including the testis
[26], the heart [27], the neural tube [28], and the neural
crest [29].
In this report, we describe a so-far-unknown role for
Sox9 in the development and maintenance of the mam-
malian hair. We show that Sox9 is activated in hair plac-
odes at the time of induction and is continuously ex-
pressed in the bulge and ORS of the hair follicle. We
further provide data that while Sox9 seems to be dis-
pensable for hair induction, it is essential for normal
hair formation and cycling. Indeed absence of Sox9
leads to a complete loss of CD34-positive stem cells,
suggesting that it is required for the maintenance of
this important cell lineage.
Results
Analysis of Sox9 Expression during Hair
Formation and Cycling
Sox9 expression was analyzed by in situ hybridization
during hair follicle development. Activation was found
at E12.5 in whisker pads (data not shown) and as early
as E14.5 in hair placodes (Figure 1). Sectioning of in situ
hybridized tissues or immunofluorescent analysis with
Sox9 antibodies demonstrated strong staining in the
thickening epithelial component and absence from the
underlying mesenchyme. Sox9 remained to be expressed
during the downgrowth of the placode but at E18.5, be-
came restricted to the presumptive outer root sheath
(ORS) layer. Sox9 could be detected in the nuclei of
K14-positive cells, a specific marker for the ORS. Sox9
expression was maintained at all stages of hair cycling.
During anagen (P8) Sox9-positive cells were abundant;
however, at the lower part of the hair follicle, ORS cells
lacked Sox9 expression (Figures 1D and 1E). Similarly,
ORS cells at the infundibulum appeared to be negative
for Sox9. Sox9 remained to be expressed at catagen
(P17) (Figure 1F). At telogen stage (P21), a small num-
ber of cells positive for Sox9 were located at the base
of the follicle epithelium, presumably representing
bulge cells (Figure 1G).
The bulge compartment contains slowly cycling stem
cells that are important for replenishing the pool of folli-
cle cells during hair cycling. Stem cells in the bulgehave been demonstrated to express high levels of
CD34 [6, 30–32]. Double labeling with CD34 demon-
strated that Sox9 is expressed in most, if not all, stem
cells (Figure 1H). To clearly identify whether all CD34
positive cells also express Sox9, we performed confo-
cal-microscope-aided 3D reconstruction. Careful analysis
demonstrated that all CD34-positive cells also showed
Sox9 staining (see Movie S1). Apart from the hair folli-
cle, Sox9-positive cells were also present in the seba-
ceous gland (data not shown).
Skin-Specific Inactivation of Sox9
Leads to Alopecia
To analyze the function of Sox9 in hair formation, we
made use of a Cre transgenic line (Y10:Cre) that was
recently generated in our lab and showed strong ec-
topic expression of the Cre recombinase in the de-
veloping epithelial layer. Developmental analysis of Cre
activity with a PGK-driven indicator mouse strain
(pgklxneoLacZ) [33] showed activation of the Cre re-
combinase in the epithelial component of developing
skin as early as E14.5 (Figure 2 and data not shown).
To investigate the role of Sox9 during hair develop-
ment, we crossed Sox9flox/flox mice with Y10:Cre trans-
genic animals. Immunofluorescent analysis was per-
formed to determine the efficiency of Cre-mediated
excision of Sox9 at various stages of development. At
E15.5, deletion of Sox9 was incomplete in skin epithe-
lium, and most of the hair placodes still expressed the
protein (data not shown). At E18.5, Sox9 protein was
dramatically reduced and at P2 virtually absent from
caudal skin of Y10:Cre; Sox9 flox/flox mice (Figures 2D
and 2E). Careful immunofluorescent analysis at various
stages after birth showed that only very few hair folli-
cles (<1%) were able to escape Cre-mediated excision
of Sox9 (data not shown).
Heterozygous deletion of Sox9 (Y10:Cre; Sox9 flox/+) in
skin had no obvious effect on development and animals
showed normal coat formation. In contrast, Y10:Cre;
Sox9flox/flox animals developed severe hair abnormali-
ties and appeared hairless in the caudal part of the
body (Figure 2C). Despite the nude appearance of Sox9
knockout mice, careful observation demonstrated the
presence of small, atrophic hair. The mouse has three
main hair types (Guard, zig-zag, and awl), which can be
clearly distinguished by their size and shape (Figure 2F)
[34]. Macroscopic analysis of plucked hair from P21
Y10:Cre; Sox9 flox/flox mice demonstrated dramatically
smaller hair, and the different types were virtually im-
possible to distinguish (Figure 2G). Moreover, during
the plucking, we noticed that hair from knockout skin
broke off easily, pointing to a fragility of the hair shaft.
Scanning electron microscopy confirmed these find-
ings on an ultrastructural level (Figures 2H and 2I).
Histological Analysis of Hair Development
in Sox9 Knockout Skin
We next performed histological analysis to study the
knockout phenotype during hair follicle development
and cycling. From E15.5 to E18.5, no obvious histologi-
cal abnormalities could be found and the number of
hair placodes in Y10:Cre; Sox9 flox/flox animals was sim-
ilar to that in control littermates (compare Figure 3B
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Hair Development and Cycling
(A) In situ hybridization analysis at E14.5 dem-
onstrates Sox9 expression in the developing
hair placode (arrowheads).
(B) Cross-section of in situ hybridized tissue
at E15.5 reveals strong staining in the epithe-
lial ectoderm of the developing hair placode.
A dashed line demarcates the border be-
tween the epithelial and the mesenchymal
component.
(C–G) Sox9 protein (red) localization during
hair follicle development and cycling (blue,
DAPI). (C) At E18.5 Sox9 protein can be de-
tected in the downgrowing hair germ. The
presumptive matrix cells are negative. (D) P8
(first anagen). With exception of the lower
and upper (infundibulum) part of the follicle,
Sox9 activation can be seen along the entire
length of the ORS. (E) Costaining with the
ORS marker K14. (F) P17 (Catagen). (G) P21
(Telogen). Sox9 is restricted to few cells at
the lower portion of the hair follicle. Note the
absence of signal in the secondary hair
germ (asterisk).
(H) At P25, Sox9 (green) is located in the nu-
clei of the hair stem cells, which express the
molecular marker CD34 (red). Scale bars
represent 100 m.By P8, there appeared to be increased cellularity in the The normal hair cycle in the mouse lasts approxi-
Figure 2. Tissue-Specific Knockout of Sox9
in the Epidermis
(A and B) The Cre-mediated deletion of the
Y10:Cre line was analyzed by crossing this
strain with pgklxneolacZ mice. Blue staining
was restricted to the epithelial component of
the developing skin.
(C) Y10:Cre crossed onto the Sox9 flox/flox
background leads to alopecia in the caudal
region of the body. Note: the presence of hair
in the head/shoulder region is due to an inef-
ficient Cre activity in the Y10:Cre line (data
not shown).
(D and E) Comparison of Sox9 antibody stain-
ing between wild-type and Y10:Cre; Sox9 flox/
Sox9 flox dorsal skin at P2. Note the complete
absence of Sox9 in knockout skin (E).
(F and G) In contrast to the clearly distin-
guishable main hair types (zig-zag, awl, guard)
in wild-type animals, hair in knockout mice
is atrophic and morphologically indistin-
guishable.
(H and I) Scanning electron microscopic
analysis confirming the short and highly ab-
normal hair in KO tissue (I) compared to wild-
type hair (H).with Figure 3A). Between P6 and P14, knockout animals d
tshowed a marked change in the follicular epithelium.ermis, and the number of bulb matrix cells appeared
o be decreased (Figure 3D).
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Development and Hair Cycling
(A and B) At E18.5, animals depleted for
Sox9 in the skin develop hair placodes (B)
similar to their control littermates (A).
(C and D) At P8, a marked reduction of the
length of the hair bulb is detected in the ab-
sence of Sox9 (D), when compared to control
littermates (double-headed white arrows in
the insets) (C).
(E–H) After the first hair cycle, the number of
hair follicles decreases. Dramatic degenera-
tion of the hair follicle is observed (asterisk
in [F]). Note the thickening of the epidermis
(arrowheads in [F] and [H]). Scale bars repre-
sent 100 m.mately 25 days with the onset of catagen at approxi-
mately P16 and telogen at P21. The second phase of
hair growth commences at P25 by a process that re-
quires Wnt/β-catenin and Shh signaling [11]. Hair folli-
cles in Y10:Cre; Sox9 flox/flox animals remained after the
first hair cycle (P25), although their number appeared
to be reduced with a marked decrease at P60 (compare
Figure 3H with Figure 3G). Beside the severely abnor-
mal hair follicle, we also noticed a significant thickening
of the epidermis with scarring at the later time points
(P60).
Ectopic Expression of Epidermal Markers in the
Mutant ORS and Absence of the Bulge
To detect differences in differentiation, we analyzed the
distribution of a variety of molecular markers in wild-
type and mutant animals. Cytokeratin expression corre-
lates with differentiation and shows specific pattern of
expression in developing and adult skin. K17, an ORS-
specific marker, remained to be expressed in mutant
animals (Figures 4A and 4B and data not shown). Simi-
larly, K5 and K14, two genes normally present in the
ORS and basal cell layer of the epidermis were ex-
pressed in the expected pattern (Figures 4C, 4D, 4F,
and 4G and data not shown). Surprisingly, markers K1
and K10, which in wild-type skin are restricted to the
suprabasal cell layer of the epidermis (Figures 4C and4F), were now also detected within the hair follicles in
Y10:Cre; Sox9 flox/flox animals (Figures 4D, 4E, 4G, and
4H). K1 and K10 were, however, absent from the most
basal layer of the epidermal sheath of the mutant hair,
as demonstrated by double labeling with K14 (Figures
4E and 4H).
Recent studies have identified several transcription
factors with important functions during hair follicle de-
velopment. Foxe1, a member of the winged helix family,
is also expressed in the ORS but, in contrast to Sox9,
is switched on at a later stage during development
(E17.5) and then restricted to the lower part of the hair
follicle ([35] and Figure 4I). Expression analysis at P4,
P8, and P17 detected strong Foxe1 expression in
knockout tissue (Figure 4J and data not shown), dem-
onstrating that this factor is initially not affected by the
absence of Sox9. By P35, however, Foxe1 protein re-
mained in only a few cells in the highly abnormal hair
follicles (data not shown).
GATA3 belongs to the GATA transcription factor fam-
ily and has recently been shown to have an important
function in determining the IRS cell lineage [36]. GATA3
expression can be found in the IRS at the lower part of
the hair follicle and in the basal cell layer of the epider-
mis (Figure 4K). In Sox9 knockout mice, GATA3 re-
mained to be expressed in the proximal part of the IRS.
Surprisingly, additional GATA3-positive cells were now
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cific Marker Genes
(A and B) The ORS marker K17 remains to be
expressed in the mutant epidermal sheath. In
contrast, a dramatic expansion of GATA3 (red)
expression domain from the basal layer to
K17-positive cells (green) of the ORS (arrow-
head) can be detected (compare also with
[K] and [L]).
(C–H) Expression of K1 (green) and the ORS
marker K14 (red) and (F–H) K10 (green) and
K14 (red). K1 and K10 expression in wild-
type tissue (C and F) are restricted to the su-
prabasal cell layer of the epidermis, whereas
knockout skin shows strong staining within
the hair follicle at P17.
(I and J) Expression of the transcription fac-
tor Foxe1 (red) in the lower ORS is not af-
fected by the knockout of Sox9 (arrowhead).
(K) GATA3 (red) in wild-type tissue is re-
stricted to the lower part of the IRS (arrow)
and the basal layer of the epidermis (arrow-
head). No Sox9 (green)/GATA3 (red) double-
positive cells could be detected.
(L) In contrast, in Sox9 knockout skin, GATA3
can be seen along the length of the hair shaft
(arrowheads) as well as in the IRS (arrow).
Scale bars represent 100 m.also detected in the most outer layer of the abnormal w
lhair follicle (Figure 4L). Double staining with the ORS
marker K17 demonstrated that the GATA3-positive cells P
astill have characteristics of the ORS (Figure 4B). Inter-
estingly, GATA3 expression in knockout ORS cells was b
aalready detectable at P4, a time point when histological
abnormalities are still relatively minor. We conclude that 6
nlack of Sox9 leads to the acquirement of epidermal
characteristics in the ORS with a multicellular appear- s
tance and the expression of GATA3 and, in the more
apical cells, the expression of K1 and K10. P
rThe bulge is part of the ORS and constitutes a reser-
voir of stem cells for the skin and hair. Stem cells in the (
bulge express the surface marker CD34, keratin15, and
S100-A6, among others [32]. Sox9 is expressed in a
wmost, if not all, CD34-positive cells (Figures 1H and 5A
and Movie S1). To test whether Sox9 affects the forma- h
wtion of the bulge, we analyzed tissues at different
stages after the first hair cycle. In contrast to wild-type s
iskin, CD34-expressing cells never appeared in Y10:Cre;
Sox9 flox/flox (Figure 5B). Similarly, keratin 15 and S100- c
A6 signal was dramatically reduced in Sox9 knockout
animals (compare Figures 5C–5F), indicating that Sox9 S
Hhas an important function for the formation of the
bulge. T
t
sProliferation Defects in the Hair Matrix Cells
Histological analysis of Sox9 mutant skin suggested a t
areduction of cell number in the highly proliferating mat-
rix cells of the hair bulb (Figures 3C and 3D). To address shether this decrease was caused by reduced cell pro-
iferation or by an increase in apoptosis, we performed
CNA/BrdU and TUNEL analyses, respectively. Prolifer-
ting cells in normal mouse skin are mostly found in the
asal cell layer of the epidermis, the ORS and the
ctively dividing matrix cells of the hair bulb (Figures
A and 6B). Analysis of knockout mice showed no sig-
ificant difference of proliferation at E18.5, P2, or P4,
uggesting that the initial proliferative capacity within
he hair follicle is not disturbed (data not shown). From
8, a marked reduction of cell proliferation in the matrix
egion could be observed with BrdU/PCNA labeling
Figures 6C and 6D).
The growing hair (anagen) normally shows very little
poptosis and at P8. TUNEL staining in control animals
as restricted to a small proportion of cells within the
air shaft (Figure 5E). In the hair bulb, no apoptotic cells
ere detectable (Figure 5F). In contrast, Sox9 knockout
kin demonstrated a significant increase of apoptosis
n the lower part of the ORS and in particular the pre-
ortex of the hair bulb (Figures 5G and 5H).
ox9 Is Dispensable for Early
air Follicle Development
he early time point of Sox9 expression at E14.5 within
he hair placode raised the possibility that this gene
erves an important function during hair induction. Al-
hough the analysis with the Y10:Cre line demonstrated
n important function of Sox9 within the outer root
heath, the Cre activity was insufficient to completely
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1345Figure 5. Lack of Sox9 Results in the Absence of Hair Stem Cells
as Detected by Immunofluorescent Staining for CD34, K15, and
S100-A6
(A and B) Double staining for CD34 (red) and Sox9 (green).
(C and D) Double staining for K15 (red) and Sox9 (green).
(E and F) Detection of S100-A6 (green). Scale bars represent 100 m.delete Sox9 at E14.5 during hair formation, and a pro-
portion of cells continued to express Sox9 protein until
P2. To test the early function of Sox9 during hair forma-
tion, we made use of homozygous knockout animals
that were created with germline-specific Cre lines (XX
ZP3:Cre; Sox9flox/flox × XY Prm:Cre; Sox9flox/flox) [26].
Homozygous knockout animals die at E11.5 because of
heart failure, which precludes a straightforward analy-
sis of hair formation in these animals [27]. Sox9 expres-
sion in whisker formation can be detected as early as
E12.5 (data not shown), and we tested whether trans-
plantation experiments may allow us to address Sox9
function in early hair formation. The upper lips of wild-
type control and homozygous Sox9 knockout animals
were transplanted under the kidney capsule of nude
mice and development allowed to proceed in vivo (Fig-
ure 7A). 10 days after transplantation, clear hair forma-tion with strong Sox9 staining in the ORS could be de-
tected in wild-type animals (Figures 7C and 7E). Sox9
mutant tissues also showed the formation of hair devel-
opment (Figures 7B and 7D). Immunohistological analy-
sis confirmed the absence of Sox9 protein in knockout
tissue, whereas K14 remained to be expressed in the
newly formed ORS (Figure 7F). We conclude that Sox9
does not appear to be essential for early development
of the hair follicle.
Sox9 Expression Depends on Shh Signaling
and Is Activated in Basal Cell Carcinomas
The early expression pattern of Sox9 in the epithelial
placode is reminiscent of Shh expression. To test
whether Sox9 acts upstream or downstream of this sig-
naling protein, we analyzed tissue samples from Shh
knockout animals [37]. At E18.5 Sox9-positive signal
was virtually absent from Shh−/− tissues suggesting
that its expression depends on the presence of this sig-
naling molecule (Figure 8B). In the skin, Shh appears
to act mainly through the transcriptional activator Gli2.
Similarly to our findings in Shh−/− tissues, Sox9 anti-
body staining on Gli2−/− sections showed a dramatic
reduction of Sox9 signal (Figure 8C).
Ectopic expression of Shh, Gli2, or an activated ver-
sion of Gli2 missing its N-terminal repression domain
(NGli2) has been shown to cause skin tumors [38–40].
To test whether Shh signaling is not only required but
also sufficient to induce Sox9 expression, we tested
samples from mice ectopically expressing NGli2 un-
der control of the basal-cell-layer-specific K5 promoter
[41]. Indeed, nuclear Sox9 protein could be readily de-
tected in tumor tissues from DNGli2 transgenic mice
(Figure 8D). Strikingly, also the epidermal basal cell
layer that did not show signs of tumor formation exhib-
ited Sox9-positive cells, suggesting that the activation
of Sox9 by Gli2 is an early, if not direct, event (Figure
8D, inset).
The expression of Sox9 in mouse Gli2 tumor samples
raised the possibility that SOX9 is also upregulated in
human skin tumors. SOX9 antibody staining on human
control skin showed strong nuclear staining in the ORS,
sebaceous glands, and sweat glands (Figure 8E and
data not shown). Additional cytoplasmic staining was
present in the epidermis, which, however, seemed to
be unspecific because no expression in this tissue
could be detected by in situ hybridization (Figure 8F).
We next investigated biopsies from patients suffering
from pilomatricoma, squamous cell carcinoma (SCC),
or basal cell carcinoma (BCC). Antibody staining in
samples from pilomatricoma and SCC were found to be
negative for SOX9 expression. In contrast, SOX9 was
highly expressed in four out of four BCC tumors ana-
lyzed (Figures 8G and 8H).
Discussion
The ORS forms the outer-most epithelial layer of the
hair follicle and as such represents a direct continua-
tion of the basal layer of the epidermis. Aside from the
demonstration that stem cells migrate along the ORS
to reach the hair bulb, little is known about the role of
this cell lineage during hair formation [13]. Our present
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1346Figure 6. Sox9 Null Hair Follicles Show a Dra-
matic Decrease in Proliferation and an In-
crease in Apoptosis
(A–D) BrdU proliferation analysis at P8 dem-
onstrates a substantial reduction of prolif-
erating cells in the matrix of the Y10:Cre;
Sox9 flox/flox hair bulb (C–D) compared to
wild-type littermates (A–B). Dotted lines out-
line hair follicles.
(E–H) In contrast, apoptotic activity (TUNEL
assay) is markedly increased in the precor-
tex (arrowheads) and the ORS (arrows) of
knockout tissue (G–H). (F) and (H) are higher
magnifications (40×) of (E) and (G) (20×), re-
spectively. Scale bars represent 100 m.study has now uncovered a crucial role for the tran- c
mscription factor Sox9 in ORS formation and the mainte-
nance of the hair throughout life.
S
ASox9 Is Dispensable for Early Hair Follicle Formation
during Embryogenesis t
sSox9 activation during hair development occurs as
early as E14.5 during mouse embryogenesis in the epi- i
tthelial hair placode. As such, Sox9 is one of the first
genes known to be expressed during hair follicle induc- s
ntion. Despite this early expression, tissue-specific dele-
tion of Sox9 with our Cre line resulted in the same num- m
cber of hair follicles, although one has to take into
account that Sox9 deletion at this early time point was F
mnot complete. However, taken together with our results
that upper lips from Sox9-null embryos developed hair P
Sfollicles when transplanted under kidney capsules,
these data suggest that Sox9 is not essential for early O
tfollicle formation. Alternatively, there could be another
member of the Sox gene family that may complement t
for the loss of Sox9. Partial functional redundancy be-
tween Sox9 and other genes of the same Sox subtype i
Shas already been observed before in other tissues [26,
28]. To our knowledge, the only other three Sox genes n
pdescribed to be expressed during hair development are
the mesenchyme-specific gene Sox18 and the melano- f
tcyte regulators Sox10 and Sox13 [42–45]. The forma-
tion of hair follicles in Sox9-null embryos may not be m
mtoo surprising in the light of the Shh-dependent Sox9
activation. Shh knockout animals also form hair folli- lles, which, however, arrest at an early time of develop-
ent [46].
ox9 Is Required for the Maintenance of the ORS
t birth, the follicle has reached into deeper areas of
he underlying mesenchyme (dermis), and the first hair
hafts develop. At this time point, expression of Sox9
n wild-type tissue becomes restricted to the ORS of
he developing hair. Hair bulb, matrix, and precortex in
kin lacking Sox9 appear to develop at least initially
ormally, as demonstrated by histological analysis, nor-
al proliferation figures at P2, and the expression of
ell-type-specific markers such as GATA3 (IRS) and
oxe1 (lower part of the ORS). Morphological abnor-
alities in knockout skin first become apparent at P4/
6, with dramatic changes occurring by P8. Because
ox9 expression at this time point is restricted to the
RS, we can conclude that this cell layer has an essen-
ial function for the development and maintenance of
he hair follicle and the growth of the hair shaft.
Our molecular analysis points to a function of Sox9
n the maintenance of ORS cell identity, and lack of
ox9 leads to the activation of several markers that are
ormally restricted to the epidermis. These include ex-
ression of the transcription factor GATA3, which, apart
rom IRS, can also be found in the basal cell layer of
he epidermis [36]. Moreover, we observed that the nor-
ally single-cell layer of the ORS developed into a
ulticellular layer in the absence of Sox9. Suprabasal
ayers of this abnormal sheath expressed the markers
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1347Figure 7. Sox9 Function Is Dispensable for
Hair Follicle Formation
(A) The upper lip of E11.5 wild-type or homo-
zygous Sox9 knockout embryos (see text)
were transplanted under the kidney capsule
of nude mice.
(B) Macroscopic view of Zp3:Cre; Prm3:Cre;
Sox9 flox/flox tissue 10 days after transplanta-
tion. Note the presence of highly pigmented
hair follicles.
(C and D) Hematoxylin- and eosin-stained
sections of wild-type (C) and mutant trans-
plants (D). Black asterisk, epidermis; arrow,
hair follicle.
(E and F) Immunofluorescent analysis of trans-
planted material with antibodies against Sox9
(green) and K14 (red). Note the presence of
Sox9 nuclear stain in wild-type (E) and a
complete absence of Sox9 staining in mu-
tant (F) hair bulbs (white arrow). White aster-
isk, K14-positive basal layer of the epider-
mis. Scale bars represent 100 m.cause of the absence of infundibulum-specific markers, However, in the epithelial sheath of mutant hair, the
Figure 8. Sox9 Acts Downstream of Shh and
Gli2 and Is Upregulated in Basal Cell Car-
cinoma
(A–C) Wild-type E18.5 tissue samples with
strong expression of Sox9 in the downgrow-
ing hair germ (white arrows). In contrast,
Shh−/− (B) or Gli2−/− (C) skin show a dramatic
reduction of Sox9 expression in hair germs.
(D) Dramatic upregulation of Sox9 in a basal
cell carcinoma (arrow) in mice expressing a
constitutively active version of Gli2 (NGli2)
under control of the K5 promoter. Inset: high-
power view of an epidermal part of (D). Note
that Sox9 is already expressed in the basal
layer of K5:DNGli2 transgenic mice before the
development of a tumor (black arrowhead).
(E) Human tissue samples of control skin
show strong nuclear staining with a Sox9 an-
tibody in the ORS of hair follicles. Cytoplas-
mic staining in the epidermis is nonspecific
background as demonstrated by in situ hy-
bridization with a Sox9 antisense probe (F).
(G and H) Basal cell carcinoma shows upreg-
ulation of SOX9 protein with strong nuclear
staining (arrowheads in [H]). Scale bars rep-
resent 100 m.K1 and K10, which are normally restricted to the supra-
basal layers of the epidermis and infundibulum. Be-we cannot completely exclude the possibility that ORS
cells in Sox9 mutants are replaced by infundibular cells.
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awas absent from normal infundibulum, would argue
against this explanation and support the hypothesis of w
wa differentiation of the ORS into an epidermal cell type.
This trans-differentiation is, however, incomplete be- T
hcause the ORS-specific marker K17 remains to be ex-
pressed in the hair shaft. We conclude that Sox9 func- H
btions to maintain ORS identity and that loss of this
transcription factor leads to the acquirement of epider-
tmal characteristics.
t
rSox9 and the Bulge: A Role in Stem Cell
vMaturation/Cell Migration?
sCompelling evidence from recent publications demon-
dstrate that hair follicle stem cells reside in the bulge,
mwhich becomes apparent at about 3 weeks after birth.
iIt is clear that stem cells must already exist at an earlier
etime point to supply the growing hair continuously with
gcells but possibly also to contribute to wound healing.
aAlthough these cells have not been identified so far,
they are likely to reside within the ORS. Interestingly,
Shair follicles of our Sox9 knockout mice showed a
cmarked decrease of proliferation in the matrix as early
tas P8. The fact that Sox9 is not expressed in the matrix
asuggests that this proliferative defect is secondary.
wSince decreased proliferation occurs very early after
aSox9 deletion, we may speculate that Sox9 is either re-
iquired for the survival of these stem cells or, alterna-
btively, for guiding stem cells to the hair bulb.
aAfter completion of the first hair cycle, the bulge is
sreadily detectable by the presence of CD34-positive
bcells. Our results indicate that Sox9 is expressed in
ubulge stem cells. Although several genes have been
didentified by microarray and quantitative PCR analysis
gon enriched hair follicle stem cells [6, 30, 32], to our
sknowledge, Sox9 represents the first transcription fac-
dtor that has been confirmed to be expressed on a cellu-
flar level in this cell type. Interestingly, hair-stem-cell-
pspecific markers were absent from the follicles lacking
Sox9. Moreover, the reduced proliferation rate in matrix
cells, together with the fact that hair follicles get lost C
over time, may suggest that Sox9 is not only expressed T
in stem cells but has also an essential function for a
their survival. d
a
Sox9 as a Downstream Target of Shh Signaling: t
A Connection to Basal Cell Carcinoma m
Shh is a signaling molecule involved in many epithelial
mesenchymal interactions. Shh knockout animals de- E
velop hair placodes but fail to form mature hair follicles,
suggesting that Shh is required for proliferation and M
Tdowngrowth of the hair placode [46, 47]. Proliferative
bdefects in Shh-null animals are at least partly caused
Wby a failure of cyclinD1 and cyclinD2 activation. Expres-
g
sion of Shh at early stages of development resembled a
that of Sox9, which prompted us to test a possible in- C
gterrelation of these two molecules. The complete ab-
msence of Sox9 signal in Shh−/− skin demonstrates a di-
Yrect dependence of Sox9 expression in skin. A similar
gactivation of Sox9 by Shh signaling has been reported
t
previously during somatic chondrogenesis [48, 49]. Al- f
though Sox9 expression completely depended on Shh n
tsignaling during hair induction (Figure 7), Sox9 proteinas expressed in the absence of Shh in cartilaginous
nd other tissues (data not shown). This is in agreement
ith the phenotype observed in Shh knockout mice,
hich does not completely abolish bone formation [37].
his may at least in part be due to the presence of other
edgehog molecules such as Indian hedgehog [50].
owever in the skin IHH expression is restricted to se-
aceous glands [51].
Shh acts by binding to its receptor Patched, which
riggers the activation of members of the Gli family pro-
eins. Recent data demonstrate that Gli2 serves a key
ole in Shh signaling during embryonic hair follicle de-
elopment [41, 52]. The results in the present study
upport this hypothesis and mice lacking Gli2 show a
ramatic reduction of Sox9 in the hair follicle, whereas
ice expressing a constitutively active version of Gli2
n the basal cell layer of the epidermis (K5:NGli2) now
xpress Sox9 ectopically in this cell layer. Taken to-
ether, these data point to a very early, possibly direct,
ctivation of Sox9 by Gli2.
Genetically modified mice ectopically expressing
hh, Gli2, or NGli2 in the basal layer develop basal
ell carcinoma [39, 40, 53]. Our results demonstrate
hat tumor samples from K5:NGli2 mice express high
mounts of Sox9 in the malignant tissue. Consistent
ith this finding, four out of four human BCC samples
nalyzed in this study showed strong SOX9 expression
n the tumor tissue. At present, we cannot distinguish
etween a mere activation of Sox9 by Gli2 and a caus-
tive role of Sox9 in tumor formation. It is, however,
triking that Sox9 has recently been demonstrated to
e expressed in colon cancer, in which it seems to be
nder control of the Wnt signaling pathway [54]. In-
eed, there is now increasing evidence for a role of Sox
enes in cancer [55]. Taken together with the expres-
ion of Sox9 in hair stem cells and the proliferative
efects seen in Sox9 knockout mice, a more general
unction of Sox9 in tumorigenesis is an attractive hy-
othesis that remains to be tested.
onclusions
he data represented in this study show that Sox9 is
crucial factor to maintain the ORS identity and the
evelopment or survival of the stem cell lineage. The
ctivation of Sox9 by the Shh pathway and its upregula-
ion in skin tumors suggests a role for this gene in tu-
origenesis.
xperimental Procedures
ouse Strains
ransgenic mice expressing the Y10:Cre transgene were generated
y microinjection of the Cre recombinase under control of a human
T1 YAC construct [56]. Details on the construction of this trans-
ene are available on request. The Y10:Cre construct was isolated
ccording to [57] and injected into fertilized oocytes collected from
57Bl6/CBA F1 matings. Mice depleted for Sox9 in the skin were
enerated by crossing animals carrying the Y10:Cre transgene with
ice homozygous for the Sox9 flox allele [58]. Animals (Sox9 flox/flox;
10:Cre/+) were obtained by cross breeding and kept on a mixed
enetic background 129/C57Bl6. Mice homozygous for Sox9 dele-
ion were generated by crossing males (Prm1:Cre; Sox9 flox/flox) with
emales (Zp3:Cre; Sox9 flox/flox) as described [26]. 8-week-old Swiss
ude female mice were purchased from Charles River and used for
he upper lips transplantations. The indicator Cre mouse line [33]
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1349was used to monitor the expression of the Y10:Cre transgene in
mutant animals.
Genotyping of Mice
The presence of the Y10:Cre transgene was detected with primers
specific for the Cre recombinase gene [26].Wild-type, Sox9 flox, and
Sox9 knockout alleles were detected with primers as described [26].
Histological and Immunological Analyses
Skin samples from exactly aged knockout and control litter mates
were collected, fixed with 4% paraformadehyde overnight at 4°C,
and then embedded in paraffin. Microtome sections of 7 m thick-
ness were stained with hematoxylin and eosin. For imunohis-
tochemistry, antigenes were retrieved in 10 mM Na citrate (pH 6)
and then incubated for 45 min in blocking solution (3% BSA, 10%
donkey serum, 0.1% Triton) at room temperature. Blocking solution
was replaced by the primary antibodies prepared in diluent (3%
BSA, 3% donkey serum, 0.1% Triton) at the following concentra-
tions: K1 (rabbit, 1:100, Covance, PRB-165P), K5 (rabbit, 1:100, Co-
vance, PRB-160P), K6 (rabbit, 1:100, Covance, PRB-169P), K10
(rabbit, 1:100, Covance, PRB-159P9), CD34 (rat, PharMingen,
1:100, Clone RAM34), Gata-3 (mouse, 1:100, Santa Cruz, HCG3-
31), Cytokeratin 14 (mouse, 1:100, BioTrend, clone LL002), Foxe1
(rabbit, 1:600 [35]), Sox9 (1:1000 [28]), K17 (rabbit, 1:1000, gift of
P. Coulombe), K15 (chicken, 1:300, Covance, PCK-153P), S100-A6
(rabbit, 1:100, Lab Vision, RB-1805). When staining with mouse an-
tibodies, we used the reagents from the MOM Basic Kit according
to the manufacturer’s protocol (Vector Labs). Relevant Cy3- or Cy2-
conjugated anti-rabbit or anti-rat antibodies (1:150, Jackson
Laboratories) were used for detection of primary antibodies. Slides
were mounted by using vectashield with DAPI as mounting reagent
(Vector Labs). For light microscopy analysis, biotinylated anti-rabbit
IgG (1:150, Vector Labs) were used. They were detected with ex-
travidin peroxidase (1:150, Sigma-Aldrich), and staining was devel-
oped with DAB (Sigma-Aldrich). For BrdU labeling, pups were
weighed and injected intraperitoneally with BrdU (50 g/g of body
weight, Sigma-Aldrich). Pups were sacrificed 2 hr after injection,
and skin samples were fixed overnight in 4% paraformaldehyde and
then embedded in paraffin. Sections were cut and dewaxed, and
antigen retrieved as indicated above. BrdU incorporation was mon-
itored with 5-Bromo-2#-deoxy-uridine labeling and detection kit
(Roche Applied Science) following the manufacturer’s protocol.
Apoptosis assay was carried out with in situ cell-death detection
kit (Roche Applied Science) according to the manufacturer’s indic-
ations. Confocal analyses were carried out on 37-m-thick sec-
tions with a Zeiss confocal microscope LMD510. The three-dimen-
sional reconstructions of images were performed with Volocity
program. Light and fluorescent studies were performed with a
Leica microscope DMLB, and pictures were taken with a spot RT-
slider camera (Diagnostic instruments) and processed with Adobe
Photoshop.
Upper Lips Transplantation
Embryos homozygous for the Sox9 knockout allele were collected
in utero at E11.5 just before they died. Upper lips were dissected
out and transplanted under the capsule of anaesthetized athymic
mice. 10 days after transplantation, mice were sacrificed by cervi-
cal dislocation. Kidneys were fixed in 4% PFA overnight, and
transplants analyzed by histological techniques (see below).
In Situ Hybridization Analysis
Embryos were fixed with 4% paraformaldehyde in PBS overnight
at 4°C. Further processing of the embryos and in situ hybridization
was carried out as described [59]. Sox9 riboprobes were synthe-
sized as described [60]. In situ analysis on human sections was
performed according to [61].
X-Gal Staining
Embryos were fixed in 0.2% glutaraldehyde in 0.1 M phosphate
buffer, 2 mM MgCl2, and 5 mM EGTA for 35 min and processed as
described [62].Morphological Analyses
Hairs were picked by pulling them with forceps from the back of
transgenic and control litter mice sacrificed 21 days after birth. For
scanning electron microscopy, back skin was fixed in 2% glutaral-
dehyde at 4°C overnight, dehydrated, and then critical-point dried
and mounted on metal stubs and sputter coated with gold palla-
dium. Samples were visualized with a JEOL JSM T300 scanning
electron microscope.
Supplemental Data
Supplemental Data include a movie and can be found with this
article online at http://www.current-biology.com/cgi/content/full/
15/15/1340/DC1/.
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